• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用超声雾化发生器(usPIPAC)进行腹腔内加压雾化化疗的可行性。

Feasibility of pressurized intra peritoneal aerosol chemotherapy using an ultrasound aerosol generator (usPIPAC).

机构信息

Department of General and Transplant Surgery, University Hospital Tübingen, Tübingen, Germany.

National Center for Pleura and Peritoneum (NCPP), National Tumor Center SW Germany, Tübingen, Germany.

出版信息

Surg Endosc. 2022 Oct;36(10):7848-7858. doi: 10.1007/s00464-022-09525-y. Epub 2022 Aug 29.

DOI:10.1007/s00464-022-09525-y
PMID:36038646
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9485099/
Abstract

BACKGROUND

We tested the feasibility of ultrasound technology for generating pressurized intraperitoneal aerosol chemotherapy (usPIPAC) and compared its performance vs. comparator (PIPAC).

MATERIAL AND METHODS

A piezoelectric ultrasound aerosolizer (NextGen, Sinaptec) was compared with the available technology (Capnopen, Capnomed). Granulometry was measured for water, Glc 5%, and silicone oil using laser diffraction spectrometry. Two- and three-dimensional (2D and 3D) spraying patterns were determined with methylene blue. Tissue penetration of doxorubicin (DOX) was measured by fluorescence microscopy in the enhanced inverted Bovine Urinary Bladder model (eIBUB). Tissue DOX concentration was measured by high-performance liquid chromatography (HPLC).

RESULTS

The droplets median aerodynamic diameter was (usPIPAC vs. PIPAC): H0: 40.4 (CI 10-90%: 19.0-102.3) vs. 34.8 (22.8-52.7) µm; Glc 5%: 52.8 (22.2-132.1) vs. 39.0 (23.7-65.2) µm; Silicone oil: 178.7 (55.7-501.8) vs. 43.0 (20.2-78.5) µm. 2D and 3D blue ink distribution pattern of usPIPAC was largely equivalent with PIPAC, as was DOX tissue concentration (usPIPAC: 0.65 (CI 5-95%: 0.44-0.86) vs. PIPAC: 0.88 (0.59-1.17) ng/ml, p = 0.29). DOX tissue penetration with usPIPAC was inferior to PIPAC: usPIPAC: 60.1 (CI 5.95%: 58.8-61.5) µm vs. PIPAC: 1172 (1157-1198) µm, p < 0.001). The homogeneity of spatial distribution (top, middle and bottom of the eIBUB) was comparable between modalities.

DISCUSSION

usPIPAC is feasible, but its performance as a drug delivery system remains currently inferior to PIPAC, in particular for lipophilic solutions.

摘要

背景

我们测试了超声技术产生加压腹腔内气溶胶化疗(usPIPAC)的可行性,并将其性能与对照(PIPAC)进行了比较。

材料和方法

使用压电超声雾化器(NextGen,Sinaptec)与现有技术(Capnopen,Capnomed)进行比较。使用激光衍射光谱法测量水、Glc5%和硅油的粒度。使用亚甲蓝测定二维(2D)和三维(3D)喷雾模式。通过荧光显微镜在增强型倒置牛膀胱模型(eIBUB)中测量多柔比星(DOX)的组织穿透性。通过高效液相色谱法(HPLC)测量组织中的 DOX 浓度。

结果

液滴的中空气动力学直径为(usPIPAC 与 PIPAC):H0:40.4(CI10-90%:19.0-102.3)与 34.8(22.8-52.7)μm;Glc5%:52.8(22.2-132.1)与 39.0(23.7-65.2)μm;硅油:178.7(55.7-501.8)与 43.0(20.2-78.5)μm。usPIPAC 的 2D 和 3D 蓝色墨水分布模式与 PIPAC 基本相当,DOX 组织浓度也是如此(usPIPAC:0.65(CI5-95%:0.44-0.86)与 PIPAC:0.88(0.59-1.17)ng/ml,p=0.29)。与 PIPAC 相比,usPIPAC 的 DOX 组织穿透性较差:usPIPAC:60.1(CI5.95%:58.8-61.5)μm 与 PIPAC:1172(1157-1198)μm,p<0.001)。两种模式的空间分布均匀性(eIBUB 的顶部、中部和底部)相当。

讨论

usPIPAC 是可行的,但作为一种药物输送系统,其性能目前仍逊于 PIPAC,特别是对于亲脂性溶液。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed41/9485099/a47be49cafdd/464_2022_9525_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed41/9485099/8e1307282be1/464_2022_9525_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed41/9485099/497cb2158c6b/464_2022_9525_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed41/9485099/f2e4f7ea81d6/464_2022_9525_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed41/9485099/9c613cc4520b/464_2022_9525_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed41/9485099/532d2087e3eb/464_2022_9525_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed41/9485099/a6ed372ffed7/464_2022_9525_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed41/9485099/a47be49cafdd/464_2022_9525_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed41/9485099/8e1307282be1/464_2022_9525_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed41/9485099/497cb2158c6b/464_2022_9525_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed41/9485099/f2e4f7ea81d6/464_2022_9525_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed41/9485099/9c613cc4520b/464_2022_9525_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed41/9485099/532d2087e3eb/464_2022_9525_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed41/9485099/a6ed372ffed7/464_2022_9525_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed41/9485099/a47be49cafdd/464_2022_9525_Fig7_HTML.jpg

相似文献

1
Feasibility of pressurized intra peritoneal aerosol chemotherapy using an ultrasound aerosol generator (usPIPAC).采用超声雾化发生器(usPIPAC)进行腹腔内加压雾化化疗的可行性。
Surg Endosc. 2022 Oct;36(10):7848-7858. doi: 10.1007/s00464-022-09525-y. Epub 2022 Aug 29.
2
Comparison between microcatheter and nebulizer for generating Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC).微导管与雾化器在生成腹腔内加压雾化化疗(PIPAC)中的比较。
Surg Endosc. 2021 Apr;35(4):1636-1643. doi: 10.1007/s00464-020-07546-z. Epub 2020 Apr 20.
3
Pressurized Intra-peritoneal Aerosol Chemotherapy (PIPAC) Endoscopical Microcatheter System.腹腔内加压气雾化疗(PIPAC)内镜微导管系统
Anticancer Res. 2018 Jun;38(6):3447-3452. doi: 10.21873/anticanres.12613.
4
Exploring the Spatial Drug Distribution Pattern of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC).探索腹腔内加压气溶胶化疗(PIPAC)的空间药物分布模式。
Ann Surg Oncol. 2016 Apr;23(4):1220-4. doi: 10.1245/s10434-015-4954-9. Epub 2015 Nov 9.
5
A multi-nozzle nebuliser does not improve tissue drug delivery during PIPAC.多喷嘴雾化器不能提高 PIPAC 期间的组织药物输送。
Surg Endosc. 2024 Oct;38(10):5832-5841. doi: 10.1007/s00464-024-11172-4. Epub 2024 Aug 19.
6
Evaluating the Effect of Micropump© Position, Internal Pressure and Doxorubicin Dosage on Efficacy of Pressurized Intra-peritoneal Aerosol Chemotherapy (PIPAC) in an Ex Vivo Model.在体外模型中评估Micropump©位置、内部压力和阿霉素剂量对腹腔内加压气溶胶化疗(PIPAC)疗效的影响。
Anticancer Res. 2016 Sep;36(9):4595-600. doi: 10.21873/anticanres.11008.
7
Effect of Liposomal Doxorubicin in Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC).脂质体阿霉素在加压腹腔气溶胶化疗(PIPAC)中的作用
J Cancer. 2018 Oct 20;9(23):4301-4305. doi: 10.7150/jca.26860. eCollection 2018.
8
Distribution pattern and penetration depth of doxorubicin after pressurized intraperitoneal aerosol chemotherapy (PIPAC) in a postmortem swine model.在猪死后模型中进行腹腔内加压雾化化疗(PIPAC)后阿霉素的分布模式及渗透深度
J Cancer Res Clin Oncol. 2016 Nov;142(11):2275-80. doi: 10.1007/s00432-016-2234-0. Epub 2016 Sep 2.
9
Pressurized intra-peritoneal aerosol chemotherapy (PIPAC): increased intraperitoneal pressure does not affect distribution patterns but leads to deeper penetration depth of doxorubicin in a sheep model.腹腔内加压气溶胶化疗(PIPAC):增加腹腔内压力不会影响分布模式,但会导致多柔比星在绵羊模型中的渗透深度更深。
BMC Cancer. 2021 Apr 26;21(1):461. doi: 10.1186/s12885-021-07955-w.
10
Concentrations of cisplatin and doxorubicin in ascites and peritoneal tumor nodules before and after pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal metastasis.腹腔内压力雾化化疗(PIPAC)前后腹腔转移患者腹水中顺铂和阿霉素浓度及腹膜肿瘤结节浓度。
Eur J Surg Oncol. 2018 Jul;44(7):1112-1117. doi: 10.1016/j.ejso.2018.04.020. Epub 2018 May 4.

引用本文的文献

1
Design and Validation of an Impaction-Nozzle Nebuliser for Enhanced Distribution Uniformity in Pressurised Intraperitoneal Aerosol Chemotherapy (PIPAC) Applications.用于增强腹腔内加压气溶胶化疗(PIPAC)应用中分布均匀性的冲击式喷嘴雾化器的设计与验证
Ann Surg Oncol. 2025 Jun 25. doi: 10.1245/s10434-025-17602-4.
2
A novel nebulized drug delivery system based on an innovative high-pressure peristaltic pump availably applied to pressurized intraperitoneal aerosol chemotherapy.一种基于创新型高压蠕动泵的新型雾化药物输送系统,可有效应用于加压腹腔雾化化疗。
J Gastrointest Oncol. 2025 Feb 28;16(1):234-248. doi: 10.21037/jgo-2024-1009. Epub 2025 Feb 23.
3

本文引用的文献

1
Technology development of hyperthermic pressurized intraperitoneal aerosol chemotherapy (hPIPAC).高热加压腹腔内雾化化疗(hPIPAC)技术的发展。
Surg Endosc. 2021 Nov;35(11):6358-6365. doi: 10.1007/s00464-021-08567-y. Epub 2021 Jun 10.
2
Intraperitoneal aerosolized drug delivery: Technology, recent developments, and future outlook.腹腔内雾化药物输送:技术、最新进展和未来展望。
Adv Drug Deliv Rev. 2020;160:105-114. doi: 10.1016/j.addr.2020.10.015. Epub 2020 Oct 24.
3
Splanchnic microcirculatory changes during CO2 laparoscopy.
Efficacy and Insights from an Extensive Series of Cytoreductive Surgery for Peritoneal Neoplasms: A High-Volume Single-Center Experience.
大量腹膜肿瘤细胞减灭术的疗效与见解:一项高容量单中心经验
Cancers (Basel). 2024 Dec 19;16(24):4229. doi: 10.3390/cancers16244229.
4
Performance of different nebulizers in clinical use for Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC).不同雾化器在腹腔内压力雾化化疗(PIPAC)临床应用中的性能。
PLoS One. 2024 May 2;19(5):e0300241. doi: 10.1371/journal.pone.0300241. eCollection 2024.
二氧化碳腹腔镜手术期间内脏微循环的变化
J Am Coll Surg. 1997 Apr;184(4):378-82.